News | January 23, 2026
Shionogi boosts stake in ViiV Healthcare in $2.125 billion deal, Pfizer exits
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
This development marks a substantial improvement in the company's financial position and reflects strengthened promoter confidence
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
Renalyx will continue operating as an independent unit within the group
The proposed transaction will be effected as a share swap
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Adcock Ingram has been a cornerstone of healthcare in South Africa, known for its trusted medication brands such as Panado, Myprodol, Epi-Max, Citro-soda and Allergex
BIL also holds an option to increase its equity stake by an additional 15%
Mansam, founded in 2022, is positioned as the first Arabian luxury fragrance brand with a vision for global expansion
Subscribe To Our Newsletter & Stay Updated
